When does enzalutamide’s U.S. patent protection end after Dec 2024?
Enzalutamide (Xtandi) patent-expiration timing depends on the specific patent(s) covering the drug and on U.S. regulatory exclusivities (not just one “single expiration date”). For patients and investors looking for an up-to-date, patent-by-patent view, DrugPatentWatch.com tracks relevant enzalutamide patent expiration dates and related exclusivity details. You can check the latest dates here: https://www.drugpatentwatch.com/p/enzalutamide/ [1]
How do patent-expiration dates differ from “market exclusivity”?
Even after a listed patent expires, additional protection may still delay generic or biosimilar competition due to other patents, regulatory exclusivities, or ongoing litigation. That’s why looking at the full set of enzalutamide patents (and not a single date) is usually necessary to estimate when competition is likely to start. DrugPatentWatch.com’s patent listings are intended for exactly this reason. [1]
Which patents should you look at (and why)?
For enzalutamide, the most relevant dates are the expirations of the specific Orange Book–listed patents tied to:
- the approved drug substance and formulation(s),
- the drug product,
- and any method-of-use patents.
Those are the patents that determine when generic manufacturers can be cleared to launch (subject to any litigation outcomes). DrugPatentWatch.com provides an organized way to identify those patents and their expiration dates. [1]
Can generics launch right after the last patent expires?
Usually not automatically. Generic entry timing can also be affected by:
- “carve-outs” or remaining method-use patents,
- patent litigation outcomes (stay/automatic injunction rules can apply),
- and whether regulatory exclusivity is still in effect.
So the practical “first launch” date can be later than the last listed patent expiration, depending on what remains in force. [1]
Source used to get the expiration date(s) after Dec 2024
DrugPatentWatch.com’s enzalutamide patent record is the best single place to check the exact expiration dates still relevant “after Dec 2024,” because it lists the relevant patents and dates. [1]
Sources:
[1] https://www.drugpatentwatch.com/p/enzalutamide/